Stay updated on Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added Adrenal cortex carcinoma as a visible keyword/context reference and linked a Genetics and Rare Diseases Information Center resource. This provides additional background context and a direct external reference related to the study topic.
    Difference
    0.2%
    Check dated 2026-04-03T06:08:00.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-20T00:17:55.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3. No visible changes to study information or page layout.
    Difference
    0.1%
    Check dated 2026-03-12T19:44:44.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.4.1 to v3.4.2, which appears to be a minor technical/version update with no changes to the study record or core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:20:59.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision: v3.4.1 is now shown on the page, replacing the previous Revision: v3.4.0.
    Difference
    0.1%
    Check dated 2026-02-04T23:54:28.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Minor metadata and UI updates: glossary shown by default and revision/QC fields updated to Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0, while the older labels Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T21:40:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page.